Copertina

Determining sample size in a personalized randomized controlled (PRACTical) trial

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Rebecca M. Turner, Kim May Lee, A. Sarah Walker, Sally Ellis, Michael Sharland, Julia A. Bielicki, Wolfgang Stöhr, Ian R. White
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Statistics in Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

A hybrid approach to sample size re‐estimation in cluster randomized trials with continuous outcomes
di: Samuel K Sarkodie, et al.
Pubblicazione: (2024)

Design and sample size determination for multiple‐dose randomized phase II trials for dose optimization
di: Peng Yang, et al.
Pubblicazione: (2024)

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs
di: Jonathan C. Moyer, et al.
Pubblicazione: (2024)

Comparison of methods that combine multiple randomized trials to estimate heterogeneous treatment effects
di: Carly Lupton Brantner, et al.
Pubblicazione: (2024)

Confidence distributions for treatment effects in clinical trials: Posteriors without priors
di: Ian C. Marschner
Pubblicazione: (2024)

Review of weighted exponential random graph models frameworks applied to neuroimaging
di: Yefeng Fan, et al.
Pubblicazione: (2024)

Correction to “Propensity score weighting for covariate adjustment in randomized clinical trials”
di: Shuxi Zeng, et al.
Pubblicazione: (2024)

A sequential, multiple assignment, randomized trial design with a tailoring function
di: Holly Hartman, et al.
Pubblicazione: (2024)

Confidence intervals for odds ratio from multistage randomized phase II trials
di: Shiwei Cao, et al.
Pubblicazione: (2024)

Multiply robust generalized estimating equations for cluster randomized trials with missing outcomes
di: Dustin J. Rabideau, et al.
Pubblicazione: (2024)

Group sequential designs for clinical trials when the maximum sample size is uncertain
di: Amin Yarahmadi, et al.
Pubblicazione: (2024)

Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial
di: Johannes Krisam, et al.
Pubblicazione: (2024)

Two‐stage randomized clinical trials with a right‐censored endpoint: Comparison of frequentist and Bayesian adaptive designs
di: Luana Boumendil, et al.
Pubblicazione: (2024)

Design of randomized clinical trials with a binary endpoint: Conditional versus unconditional analyses of a two‐by‐two table
di: Edward L. Korn, et al.
Pubblicazione: (2024)

Sample size calculation for comparing two screening tests when the gold standard is missing at random
di: Yougui Wu
Pubblicazione: (2024)

Sample Size Calculation for the ROCI Design
di: Henry Bern, et al.
Pubblicazione: (2026)

Assurance methods for designing a clinical trial with a delayed treatment effect
di: James A. Salsbury, et al.
Pubblicazione: (2024)

Letter to the editor: The use of fast approximate random forests using subsampling (rfsrc.fast) does not support the conclusion on sample sizes needed for random survival forests
di: Elena Albu, et al.
Pubblicazione: (2024)

Use of win time for ordered composite endpoints in clinical trials
di: James F. Troendle, et al.
Pubblicazione: (2024)

Beyond the two‐trials rule
di: Leonhard Held
Pubblicazione: (2024)

Predicting Individual Risk of Advanced Adenoma Based on the Interval‐Censored Recurrent Adenoma Event and Informative Screening Time
di: Yipeng Wei, et al.
Pubblicazione: (2026)

Improved mortality analysis in early‐phase dose‐ranging clinical trials for emergency medical diseases using Bayesian time‐to‐event models with active comparators
di: Xiaosong Shi, et al.
Pubblicazione: (2024)

Design and Analysis of N‐Of‐1 Trials That Incorporate Sequential Monitoring
di: Shu Jiang, et al.
Pubblicazione: (2025)

Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?
di: Matthew Dodd, et al.
Pubblicazione: (2024)

Correction to “Using principal stratification in analysis of clinical trials”
di: Ilya Lipkovich, et al.
Pubblicazione: (2024)

Determining the Optimal Sequence of Multiple Tests
di: Lucas Böttcher, et al.
Pubblicazione: (2025)

A New Algorithm for Sampling Parameters in a Structured Correlation Matrix With Application to Estimating Optimal Combinations of Muscles to Quantify Progression in Duchenne Muscular Dystrophy
di: Michael K. Kim, et al.
Pubblicazione: (2025)

Robust analysis of stepped wedge trials using composite likelihood models
di: Emily C. Voldal, et al.
Pubblicazione: (2024)

Modeling intra‐individual inter‐trial EEG response variability in autism
di: Mingfei Dong, et al.
Pubblicazione: (2024)

A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials
di: Yu Du, et al.
Pubblicazione: (2024)

Adding experimental treatment arms to multi‐arm multi‐stage platform trials in progress
di: Thomas Burnett, et al.
Pubblicazione: (2024)

Efficient estimation of Cox model with random change point
di: Xuerong Chen, et al.
Pubblicazione: (2024)

A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart
di: Stephen Schüürhuis, et al.
Pubblicazione: (2024)

Dual‐agent dose‐finding in Phase I clinical trial—An extension of rapid enrollment design
di: Yunfei Wang
Pubblicazione: (2024)

Doubly adaptive biased coin design to improve Bayesian clinical trials with time‐to‐event endpoints
di: Wenhao Cao, et al.
Pubblicazione: (2024)

A General Framework to Assess Complex Heterogeneity in the Strength of a Surrogate Marker
di: Rebecca Knowlton, et al.
Pubblicazione: (2025)

A class of computational methods to reduce selection bias when designing Phase 3 clinical trials
di: Tianyu Zhan
Pubblicazione: (2024)

Dynamic path analysis for exploring treatment effect mediation processes in clinical trials with time‐to‐event endpoints
di: Matthias Kormaksson, et al.
Pubblicazione: (2024)

Inference under superspreading: Determinants of SARS‐CoV‐2 transmission in Germany
di: Patrick W. Schmidt
Pubblicazione: (2024)

A Sensitivity Analysis Framework Using the Proxy Pattern–Mixture Model for Generalization of Experimental Results
di: Rebecca R. Andridge, et al.
Pubblicazione: (2025)